Fatemeh Atyabi

Education

1. Pharm D

Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran , Iran, 1988

Thesis Title:Synthesis and study of antimicrobial effect of new nitroimidazole derivatives

2. Ph.D

pharmaceutics, Department of Medical Biophysics, Medical School, University of , Manchester, UK, 1995

Thesis Title:Preparation and Potential Application of Floating Formulations Based on Ion Exchange Resin

3. Fellowship

Nanotechnology, UMR CNRS 8612, Universite Paris-Sud, Paris, France, 2005

 

Language Skills

1. English

2. French

 

Awards & Honors

1. Unitrs States Patent Aplication Publication

2. Polycitric Acic Functionalized Carbon Nanotube Drug Delivery System

 

Experiences

Scientific Position

1. Professor of Pharmaceutics

Faculty of Pharmacy, Tehran University of Medical Sciences,

2. Head of Pharmaceutical Nanotechnology Board

Ministry of Health and Medical Education,

3. Head of department of Pharmaceutical Nanotechnology

Faculty of Pharmacy, Teheran University of Medical Sciences,

Books

English

1. Handbook of ”Particulate Drug Delivery

Authors: F. Atyabi, S. Majzoob

Publisher: American scientific publisher, 2007, Original

Abstract :

Polysaccharides as Carrier for Particulate-controlled Delivery Systems

 

2. Radiopharmaceuticals Handbook

Authors: F. Atyabi

Publisher: TUMS Publications, 2007, Original

Abstract :

Radiopharmaceuticals in Novel Drug Delivery Systems

 

Memberships

1. Controlled Release Society of Iran

Activity Type:Member

2. Controlled Release Society (U.S.A.)

Activity Type:Member

3. Member, Research committee, Medical Nanotechnology Research Centre, Tehran University of Medical Sciences

Activity Type:Member

 

Research Interests

1. Noanotechnology Based Drug Delivery Systems

our group has made advances to the basic science of polymeric nanoparticles,  carbon nanotube, Spions, and other nanostructures and their  potential applications in the areas of drug delivery, nanobiotechnolgy and  nanomedicine

2. Biomaterials and Nanomedicine

Nanomedicine lab connect the fundamental nanomaterials engineering and pharmaceutical sciences towards innovative therpeutics

3. Tissue engineering

4. Polymeric Nanostructures for Cancer Drug Delivery

Our research has focused on the science and technology of polymer based materials exclusively hybrid materials of various nanoconjugates and nanoparticles used in development of anticancers

5. Particulate drug delivery systems

6. targeted delivery systems

Antibody, aptamer, peptide and protein mediated drug Targeting

 

Papers

English

1. S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles containing Imatinib for targeting drug delivery to atherosclerotic plaques

Authors: M. Esfandyari-Manesh, M. Abdi, A. Hajhossein Talasaz, S. M. Ebrahimi, F. Atyabi, R. Dinarvand

DARU Journal of Pharmaceutical Sciences, Year. 2020,

2. Laser irradiation affects the biological identity and cellular uptake of plasmonic nanoparticles

Authors: H. Ayazi, O. Akhavan, M. Raoufi, R. Varshochian, N. Sadat Hosseini Motlagh, F. Atyabi

Nanoscale, Vol.13, Year. 2019,

3. The significance of artificial intelligence in drug delivery system design

Authors: P. Hassanzadeh, F.Atyabi, R. Dinarvand

Advanced Drug Delivery Reviews, Vol.151-152, Year. 2019, Page:169-190,

4. Apoptotic Effects of Mucin1 Aptamer-Conjugated Nanoparticles Containing Docetaxel and c-Met siRNA on SKBR3 Human Metastatic Breast Cancer Cells

Authors: N. Majidi Zolbanin, R. Jafari, J. Majidi, F. Atyabi, M. Yousefi, F. Jadidi-Niaragh, M.S. Soltani Zangbar, M. Asadi , A. Mohajjel Nayebi

JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, Vol.14, No.4, Year. 2019,

5. Design of Experiment, Preparation, and in vitro Biological Assessment of Human Amniotic Membrane Extract Loaded Nanoparticles

Authors: A. Shabani, F. Atyabi, M.R. Khoshayand, R. Mahbod, R.A. Cohan, I. Akbarzadeh, H. Bakhshandeh

Current Pharmaceutical Biotechnology, Year. 2019,

6. Immobilization of HIV‐1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery

Authors: R. P. Ahwazi, M. Kiani, M. Dinarvand, A. Assali, F. S. M. Tekie, R. Dinarvand, F. Atyabi

Cellular Physiology, Year. 2019,

7. Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link

Authors: Gh. Rezaei, S. M. Daghighi, M. Raoufi, M. Esfandyari-Manesh, M. Rahimifard, V. Iranpur Mobarakeh, S. Kamalzare, M.H. Ghahremani, F. Atyabi, M. Abdollahi, F. Rezaee, R. Dinarvand

Journal of Colloid and Interface Science, Vol.556, Year. 2019, Page:476-491,

8. Enhancement mitochondrial apoptosis in breast cancer cells by paclitaxel-triphenylphosphonium conjugate in DNA aptamer modified nanoparticles

Authors: M. Esfandyari-Manesh, A. Mohammadi, F. Atyabi, S.M.Ebrahimi, E. Shahmoradi, M. Amini, Z. H.Mirzaie, M. H. Ghahremani, R. Dinarvand

Journal of Drug Delivery Science and Technology, Vol.54, Year. 2019,

9. Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine

Authors: H. Hassannia, M. Ghasemi Chaleshtari, F. Atyabi, M. Nosouhian, A. Masjedi, M. Hojjat‐Farsangi, A. Namdar, Gh. Azizi, H. Mohammadi, Gh, Ghalamfarsa, Gh. Sabz S. Hasanzadeh, M. Yousefi, F. Jadidi‐Niaragh

Immulogy, Year. 2019,

10. Corrigendum to “The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531]

Authors: M. Alibolandi, F. Sadeghi, Kh. Abnous, F. Atyabi, M. Ramezani, F. Hadizadeh

European Journal of Pharmaceutics and Biopharmaceutics, Vol.142, Year. 2019, Page:540,

11. Mucoadhesive hydrogels for buccal drug delivery: In vitro- in vivo correlation study

Authors: R. Angela Baus, F. Zahir-Jouzdani, S. Dünnhaupt, F. Atyabi

European Journal of Pharmaceutics and Biopharmaceutics, Vol.142, Year. 2019, Page:498-505,

12. Carboxymethyl dextran‐trimethyl chitosan coated superparamagnetic iron oxide nanoparticles: An effective siRNA delivery system for HIV‐1 Nef

Authors: S. Kamalzare, Z. Noormohammadi, P. Rahimi, F. Atyabi, S. Irani, F.S. Mirzazadeh Tekie, F. Mottaghitalab

Journal of Cellular Physiology, Year. 2019,

13. The significance of artificial intelligence in drug delivery system design

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Advanced Drug Delivery Reviews, Year. 2019,

14. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy

Authors: F. Vakhshiteh, F. Atyabi, S.N. Ostad

International Journal Nanomedicine, Vol.14, Year. 2019, Page:2847–2859,

15. NANOPARTICLES RESHAPE THE BIOMEDICAL INDUSTRY

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Biomedical Reviews, Vol.29, Year. 2018, Page:17-26,

16. Laser irradiation affects the biological identity and cellular uptake of plasmonic nanoparticles

Authors: Hashemi, M. R. Hormozi-Nezhad, C. Corbo, F.S. Farvadi, M.A. Shokrgozar, M. Mehrjoo, F. Atyabi, M.H. Ghahremani, M. Mahmoudi, R. Dinarvand

Nanoscale, Vol.13, Year. 2019, Page:5775 -6500 ,

17. Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid

Authors: A. Rastegari, F. Mottaghitalab, R. Dinarvand, M. Amini, E. Arefian, M. Gholami, F. Atyabi,

Drug Delivery and Translational Research, Vol.9, No.3, Year. 2019, Page:694–706 ,

18. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway

Authors: egari, M. Hojjat-FA. Masjedi, H. Hassanni, F. Atyabi, A. Rastarsangi, A. Namdar, H. Soleimanpour, G.R. Azizi, A. Nikkhoo, G. Ghalamfarsa, A. Mirshafiey, F. Jadidi-Niaragh

International Journal of Biological Macromolecules, Year. 2019,

19. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle

Authors: V. Iranpur Mobarakeh, M.H. Modarressi, P. Rahimi, A. Bolhassani, E. Arefi, F. Atyabi, R. Vahabpour

International Journal of Biological Macromolecules, Vol.129, Year. 2019, Page:305-315,

20. New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment

Authors: F. Mottaghitalab, M. Farokhi, Y. Fatahi, F. Atyabi, R. Dinarvand

Journal of Controlled Release, Vol.295, Year. 2019, Page:250-267,

21. Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress

Authors: A. Assali, O. Akhavan, F. Mottaghitalab, M. Adeli, R. Dinarvand, S. Razzazan, E. Arefian, M. Soleimani, F. Atyabi

International Journal of Nanomedicine, Vol.13, Year. 2018, Page:5865–5886,

22. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system

Authors: A. Assali, S. Razzazan, O. Akhavan, F. Mottaghitalab, M. Adeli

Colloids and Surfaces B: Biointerfaces, Vol.173, Year. 2019, Page:891-898,

23. Dual drug delivery system of PLGA nanoparticles to reverse drug resistance by altering BAX/Bcl-2

Authors: F.Alvandifar, B. Ghaffari, N. Goodarzi, N. Shabani, Ravari, F. Karami, M. Amini, E. Souri, M.R. Khoshayand, M. Esfandyari-Manesh, Razieh MohammadJafari, F. Atyabi, S. Irani, R. Dinarvand

Journal of Drug Delivery Science and Technology, Vol.47, Year. 2018, Page:291-298,

24. Simultaneous formulation of influenza vaccine and chitosan nanoparticles within CpG oligodesoxi nucleotides leads to dose-sparing and protects against lethal challenge in the mouse model

Authors: S.F. Sadati, A. Jamali A. Abdoli M. Abedi-Valugerdi, S. Gholami S. Alipour S. Soleymani, M. Tavassoti Kheiri F. Atyabi

Pathogens and Disease, Vol.76, No.8, Year. 2018,

25. Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo, Cellular Physiology

Authors: F. Zahir‐Jouzdani F. Khonsari M. Soleimani M. Mahbod E. Arefian M. Heydari S. Shahhosseini, R. Dinarvand F. Atyabi

Cellular Physiology, Year. 2018,

26. Corneal chemical burn treatment through a delivery system consisting of TGF-β1 siRNA: in vitro and in vivo

Authors: F. Zahir-Jouzdani, M. Soleimani, M. Mahbod, F. Mottaghitalab, F. Vakhshite, E. Arefian, S. Shahhoseini, R. Dinarvand, F. Atyabi

Drug Delivery and Translational Research, Vol.8, No.5, Year. 2018, Page:1127–1138,

27. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study

Authors: G.R. Barbari, F. Dorkoosh, M. Amini, N. Bahari Javan, M. Sharifzadeh, F. Atyabi, S. Balalaie, N. Rafiee Tehrani, M. Rafiee Tehrani

International Journal of Nanomedicine, Vol.13, Year. 2018, Page:5127–5138,

28. Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells

Authors: N. Majidi Zolbanin, R. Jafari, J. Majidi, F. Atyabi, M. Yousefi, F. Jadidi-Niaragh, L. Aghebati-Maleki, D. Shanehbandi, M.S. Soltani Zangbar, A. Mohajjel Nayebi

Advanced Pharmaceutical Bulletin, Vol.8, No.3, Year. 2018, Page:383–393,

29. Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment

Authors: F. S. MirzazadehTekie, M. Soleimani, A. Zakerian, M. Dinarvand, M. Amini, R. Dinarvand, E. Arefian, F. Atyabi

Carbohydrate Polymers, Vol.201, Year. 2018, Page:131-140,

30. Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice

Authors: G. Ghalamfarsa A. Rastegari F. Atyabi, H. Hassannia M. Hojjat‐Farsangi A. Ghanbari E. Anvari J. Mohammadi G.R Azizi A. Masjedi M. Yousefi B. Yousefi J. Hadjati F. Jadidi‐Niaragh

Cellular Physiology, Vol.233, No.10, Year. 2018, Page:7165-7177,

31. Glyceryl ester surfactants: Promising excipients to enhance the cell permeating properties of SEDDS

Authors: F. Zahir-Jouzdani, N. Lupo, M. Hermann, F. Prüfert, F. Atyabi

European Journal of Pharmaceutics and Biopharmaceutics, Vol.129, Year. 2018, Page:154-161,

32. Biomolecular Corona Dictates Aβ Fibrillation Process

Authors: A. Lotfabadi, M.J. Hajipour, H. Derakhshankhah, A. Peirovi, S. Saffar, E. Shams, E. Fatemi, E. Barzegari, S. Sarvari, F. Moakedi, M. Ferdousi, F. Atyabi, A.A. Saboury, and R. Dinarvand

ACS Chemical Neuroscience, Vol.9, No.7, Year. 2018, Page:1725–1734,

33. In situ gelling and mucoadhesive polymers: why do they need each other?

Authors: F. Zahir-Jouzdani, J. Dominik Wolf, F. Atyabi, A. Bernkop-Schnürch

Expert Opinion on Drug Delivery, Vol.15, No.10, Year. 2018, Page:1007-1019,

34. , Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

Authors: R. Jafari, N. Majidi Zolbanin, J. Majidi, F. Atyabi, M. Yousefi, F. Jadidi-Niaragh, L. Aghebati-Maleki, D. Shanehbandi, M.S. Soltani Zangbar, H. Rafatpanah

Iranian Biomedical Journal, Year. 2018,

35. Multifunctional, core-shell nanoplatforms (gold@graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery

Authors: A. Assali, O. Akhavan, M. Adeli, S. Razzazan, R. Dinarvand, S. Zanganeh, M. Soleimani, M. Dinarvand, F. Atyabi

Nanotechnology, Biology and Medicine, Vol.14, No.6, Year. 2018, Page:1891-1903,

36. Cell shape affects nanoparticle uptake and toxicity: An overlooked factor at the nanobio interfaces

Authors: F.S. Farvadi, M. H.Ghahremani, F. Hashemi, M.R. Hormozi-Nezhad, M. Raoufi, S. Zanganeh, F. Atyabi, R. Dinarvand, M. Mahmoudi

Journal of Colloid and Interface Science, Vol.531, Year. 2018, Page:245-252,

37. Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress

Authors: A. Assali, O. Akhavan, F. Mottaghitalab, M. Adeli, R. Dinarvand, S. Razzazan, E. Arefian, M. Soleimani, F. Atyabi

International Journal of Nanomedicine, Vol.13, Year. 2018, Page:5865–5886,

38. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy

Authors: B. Javan, F. Atyabi, M. Shahbazi

Life Sciences, Vol.202, Year. 2018, Page:140-151,

39. Tissue engineering: Still facing a long way ahead

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Journal of Controlled Release, Vol.279, Year. 2018, Page:181-197,

40. Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand, A.R. Dehpour, M. Azhdarzadeh, M. Dinarvand

DARU Journal of Pharmaceutical Sciences, Vol.22, No.1, Year. 2018, Page:38-47,

41. Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Journal of Controlled Release, Vol.280, Year. 2018, Page:58–75,

42. siRNA delivery for treatment of degenerative diseases, new hopes and challenges

Authors: F.Zahir Jouzdani, F. Mottaghitalab, M. Dinarvand, F. Atyabi

Journal of Drug Delivery Science and Technology, Vol.45, Year. 2018, Page:428-441,

43. Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries

Authors: P. Hassanzadeh, E. Arbabi, F. Atyabi, R. Dinarvand

Life Sciences, Vol.193, Year. 2018, Page:64-76,

44. Linkers: The key elements for the creation of efficient nanotherapeutics

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Journal of Controlled Release, Vol.270, Year. 2018, Page:260-267 ,

45. Application of polycaprolactone nanofibers as patch graft in ophthalmology

Authors: H. Hashemi, S. Asgari, S. Shahhoseini, M. Mahbod, F. Atyabi, H. Bakhshandeh, A. H. Beheshtnejad

Indian Journal of Ophthalmology, Vol.66, No.2, Year. 2018, Page:225-228 ,

46. Preparation and Characterization of Nanoparticle β-Cyclodextrin:Geraniol Inclusion Complexes

Authors: Z. hadian, M. Maleki K. Abdi, F. Atyabi, A. Mohammadi, R. Khaksar

(The Iranian Journal of Pharmaceutical Research (IJPR, Vol.17, No.1, Year. 2018, Page:39-51,

47. Inhibiting influenza virus replication and inducing protection against lethal influenza virus challenge through chitosan nanoparticles loaded by siRNA

Authors: A. Jamali, F. Mottaghitalab, A. Abdoli, M. Dinarvand, A. Esmailie, M. Tavassoti, Kheiri, F. Atyabi

Drug Deliv. and Transl. Res, Vol.8, No.1, Year. 2018, Page:12-20,

48. Carbon nanotubes provide longer lasting gastroprotective effects for anandamide in stress-induced gastric ulcer in rat

Authors: P. Hassanzadeh , E. Arbabi , F. Atyabi , R. Dinarvand

Physiology and Pharmacology, Year. 2017,

49. Chitosan and thiolated chitosan: Novel therapeutic approach for preventing corneal haze after chemical injuries

Authors: F. Zahir Jouzdani, M. Mahbod, M. Soleimani, F. Vakhshiteh, E. Arefian, S. Shahosseini, R. Dinarvand, F. Atyabi,

Carbohydrate Polymers,, Vol.179, No.1, Year. 2018, Page:42-49,

50. Preparation and Characterization of Nanoparticle β-Cyclodextrin:Geraniol Inclusion Complexes

Authors: Z. hadian, M. Maleki K. Abdi, F. Atyabi, A. Mohammadi, R. Khaksar

(The Iranian Journal of Pharmaceutical Research (IJPR, Year. 2018,

51. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol

Authors: E. Gheytanchi, Z. Madjd, L. Janani, A. Rasti, R. Ghods, F. Atyabi, M. Hossein Asadi Lari, S. Babashah

Systematic Reviews, Year. 2017,

52. Aerosol delivery of ferulic acid-loaded nanostructured lipid carriers: A promising treatment approach against the respiratory disorders

Authors: P. Hassanzadeh , E. Arbabi , F. Rostami , F. Atyabi , R. Dinarvand

Physiology and Pharmacology, Year. 2017,

53. Ferulic acid, a phenolic compound with therapeutic effects in neuropsychiatric disorders, stimulates the production of NGF and endocannabinoids in rat brain

Authors: P. Hasanzadeh , E. Arbabi , F. Atyabi

Year. 2017,

54. Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy

Authors: F. Mottaghitalab, M. Kiani, M. Farokhi, S. C. Kundu, R. L. Reis, M. Gholami, H. Bardania, R. Dinarvand, P. Geramifar, D. Beiki, F. Atyabi

ACS Appl. Mater. Interfaces, Vol.9, No.37, Year. 2017, Page:31600–31611,

55. In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells

Authors: M. Ghadiri , E. Vasheghani-Farahani, F. Atyabi , F. Kobarfard, H. Hosseinkhani

(Iranian Journal of Pharmaceutical Research (IJPR, Year. 2017,

56. Interleukin-6 participation in pathology of ocular diseases

Authors: F. Zahir-Jouzdani, F. Atyabi, N. Mojtabavi

Pathophysiology, Year. 2017,

57. Design and fabrication of dual-targeted delivery system based on gemcitabine conjugated human serum albumin nanoparticles

Authors: P. Norouzi, M. amini, F. Mottaghitalab, F. S. Mirzazadeh Tekie, R. Dinarvand, Z. Hadavand Mirzaie, F. Atyabi

Chemical Biology & Drug Design, Year. 2017,

58. Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier

Authors: M. Ghadiri, E. Vasheghani-Farahani, F. Atyabi, F. Kobarfard, F. Mohamadyar-Toupkanlou, H. Hosseinkhani

Journal of Biomedical Materials Research Part A, Year. 2017,

59. Investigation of the Influence of Sucrose and Cholesterol on the Phase Transition Temperature of nanoliposomal formulation besides using particle size Reduction Techniques (Ultrasonication/High Pressure Homogenization)

Authors: Z. Malaei-Balasi, Gh. Amoabediny, D. Biria, F. Atyabi, N. Salehi-Nik, F. Haghirosadat

Journal of Shahid Sadoughi University of Medical Sciences, Vol.25, No.2, Year. 2017, Page:144-155,

60. Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells

Authors: F. Chaharband, G. Kamalinia, F. Atyabi, S.A. Mortazavi, Z. H. Mirzaie, R. Dinarvand

Artificial Cells, Nanomedicine, and Biotechnology, Year. 2017,

61. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders

Authors: P. Hassanzadeh, F. Atyabi , R. Dinarvand

Life Sciences, Year. 2017,

62. SN38 conjugated hyaluronic acid gold nanoparticles as a novel system against metastatic colon cancer cells

Authors: H. Hosseinzadeh, F. Atyabi, B. Shiri Varnamkhasti, R. Hosseinzadeh, S.N. Ostad, M.H. Ghahremani, R. Dinarvand

International Journal of Pharmaceutics, Vol.526, No.1-2, Year. 2017, Page:339-352 ,

63. Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells

Authors: P. Mahdaviani, S. Bahadorikhalili, M. Navaei-Nigjeh, S. Y. Vafaei, M. Esfandyari-Manesh, A.H. Abdolghaffari, Z. Daman, F. Atyabi, Mo.H. Ghahremani, M. Amini, A. Lavasanifar, R. Dinarvand

Materials Science and Engineering: C, Vol.80, Year. 2017, Page:301-312 ,

64. A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides

Authors: G.R. Barbari, F. Abedin Dorkoosh, M. Amini, M. Sharifzadeh, F. Atyabi, S. Balalaie, N. Rafiee Tehrani, M. Rafiee Tehrani

International Journal of Nanomedicine, Vol.12, Year. 2017, Page:3471-3483 ,

65. , Prospects of siRNA applications in regenerative medicine

Authors: F. Mottaghitalab, A Rastegari, M. Farokhi, R. Dinarvffgand, H. Hosseinkhani, K.L. Ou, D. W. Pack, C. Mao, h, M. Dinarvand

International Journal of Pharmaceutics, Year. 2017,

66. Formulation and evaluation of targeted nanoparticles for breast cancer theranostic system

Authors: P. Dadras, F. Atyabi, S. Irani, L. Ma'mani, A. Foroumadi, Z. Hadavand Mirzaie, M. Ebrahimi, R. Dinarvand

European Journal of Pharmaceutical Sciences, Vol.97, Year. 2017, Page:47-54,

67. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice

Authors: F. Jadidi-Niaragh, F. Atyabi, A. Rastegari, N. Kheshtchin, S. Arab, H. Hassannia, M. Ajami, Z. Mirsanei, S. Habibi, F. Masoumi, F. Noorbakhsh, F. Shokri, J. Hadjati

Journal of Controlled Release, Vol.246, Year. 2017, Page:46-59,

68. Application of Carbon Nanotubes for Controlled Release of Growth Factors or Endocannabinoids: A Breakthrough in Biomedicine

Authors: P. Hassanzadeh, F. Atyabi, R. Dinarvand

Biomedical Reviews, Vol.27, Year. 2016, Page:41-49,

69. Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles

Authors: M. Mahmoudi Saber, S. Bahrainian, R. Dinarvand, F. Atyabi

International Journal of Pharmaceutics, Vol.517, No.1-2, Year. 2017, Page:269-278,

70. Efficient gene delivery to primary human retinal pigment epithelial cells: The innate and acquired properties of vectors

Authors: N. Tasharrofi, F. Kouhkan, M. Soleimani, Z.S. Soheili, F. Atyabi, H. Akbari Javar, F.A. Dorkoosh

International Journal of Pharmaceutics, Vol.518, No.1-2, Year. 2017, Page:66-79,

71. Targeted delivery of cabazitaxel by conjugation to albumin-PEG-folate nanoparticles using a cysteine-acrylate linker and simple synthesis conditions

Authors: M.K. Khoeeniha, M. Esfandyari-Manesh, H. Behrouz, M. Amini, B.S. Varnamkhasti, F. Atyabi, R. Dinarvand

Current Drug Delivery, Year. 2016,

72. Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis

Authors: P. Hassanzadeh, E. Arbabi, F. Atyabi, R Dinarvand

Life Sciences, Year. 2016,

73. Preparation and Characterization of Three Tilmicosin-loaded Lipid Nanoparticles: Physicochemical Properties and in-vitro Antibacterial Activities

Authors: A.Al-Qushawi, A. Rassouli, F. Atyabi, S.M. Peighambari, M. Esfandyari-Manesh, G.R. Shams, A. Yazdani

Iranian Journal of Pharmaceutical Research, Vol.15, No.4, Year. 2016, Page:663-676,

74. Solid lipid nanoparticles surface modified with anti-Contactin2 or anti-Neurofascin for brain targeted delivery of medicines

Authors: N. Gandomi, R. Varshochian, F. Atyabi, M.H. Ghahremani, M. Sharifzadeh, M. Amini, R. Dinarvand

Pharmaceutical Development and Technology, Year. 2016,

75. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer

Authors: M. Esfandyari-Manesh, A. Mohammadi, F. Atyabi, S. M. Nabavi, S. M. Ebrahimi, E. Shahmoradi, B. Shiri Varnamkhasti, M. H. Ghahremani, R. Dinarvand

International Journal of Pharmaceutics, Vol.515, No.1-2, Year. 2016, Page:607-615,

76. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced, anticancer efficacy in breast cancer cells

Authors: 8. V. Alinejad M. Hossein Somi, B. Baradaran, P. Akbarzadeh, F. Atyabi, H. Kazerooni, H. Samadi Kafil, L. Aghebati Maleki, H. Siah Mansouri, M. Yousefi

Biomedicine & Pharmacotherapy, Vol.83, Year. 2016, Page:229-240,

77. Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke

Authors: P Hassanzadeha, E. Arbabi, , F. Atyabi, R. Dinarvand

Life Sciences, Year. 2016,

78. Nano polyelectrolyte complexes of carboxymethyl dextran and chitosan to improve chitosan-mediated delivery of miR-145

Authors: 10. F.S. Mirzazadeh Tekie, M. Kiani, A. Zakerian, F. Pilevarian, A. Asali, M. Soleimani, R. Dinarvand, E. Arefian, A. Atashi, M. Amini

Carbohydrate Polymers, Year. 2016,

79. Laser induced fluorescence spectroscopy of chemo-drugs as biocompatible fluorophores: irinotecan, gemcitabine and navelbine

Authors: 11. N.S. Hosseini Motlagh, P. Parvin, F. Ghasemi, F. Atyabi, S. Jelvani, S. Abolhosseini.

Laser Physics Letters, Vol.13, No.7, Year. 2016,

80. Docetaxel–Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study

Authors: Z. H. Mirzaie, S. Irani, R. Mirfakhraie, S. M. Atyabi, M. Dinarvand, R. Dinarvand, R. Varshochian, F. Atyabi,

Chemical Biology & Drug Design, Year. 2016,

81. Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy

Authors: P. Hassanzadeh, E. Arbabi, F. Atyabi, R. Dinarvand

Life Sciences, Year. 2016,

82. Influence of PEG Molecular Weight on Drug Delivery of Gemcitabine Conjugated to SWCNT-PEG

Authors: A. Razzazan, F. Atyabi, B. Kazemi, R. Dinarvand

Drug Delivery, Vol.13, No.8, Year. 2016, Page:1567-2018,

83. . Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells

Authors: N. Shabani Ravari, N. Goodarzi, F. Alvandifar, M. Amini, E. Souri, MR. Khoshayand, ZH. Mirzaie, F. Atyabi, R. Dinarvand

DARU Journal of Pharmaceutical Sciences , Year. 2016,

84. Pharmacokinetics and bioavailability of three promising tilmicosin-loaded lipid nanoparticles in comparison with tilmicosin phosphate following oral administration in broiler chickens

Authors: A. Rasouli, A. Al-Qushawi, F. Atyabi, SM. Peighambari, M. Esfandiari-Manesh, GR. Shamsi

Year. 2016,

85. . Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line

Authors: H. Siahmansouri, MH. Somi, Z. Babaloo, B. Baradaran, F. Jadidi-Niaragh, F. Atyabi, H. Mohammadi, M. Ahmadi, M. Yousefi

Journal of Pharmacy and Pharmacology, Year. 2016,

86. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing

Authors: M. Hajimiri, S. Shahverdi, MA. Esfandiari, B. Larijani, F. Atyabi, A. Rajabiani, AR. Dehpour, M. Amini, R. Dinarvand

Drug Development and Industrial Pharmacy, Vol.42, No.5, Year. 2016, Page:707-719,

87. . The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231). Artificial cells

Authors: P. Eivazy, F. Atyabi, F. Jadidi-Niaragh, L. Aghebati Maleki, A. Miahipour, J. Abdolalizadeh, et al.

nanomedicine, and biotechnology, Year. 2016, Page:1-16,

88. . The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231). Artificial cells

Authors: P. Eivazy, F. Atyabi, F. Jadidi-Niaragh, L. Aghebati Maleki, A. Miahipour, J. Abdolalizadeh, et al.

nanomedicine, and biotechnology, Year. 2016, Page:1-16,

89. Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy

Authors: M. Mehdizadeh, H. Rouhani, N. Sepehri, R. Varshochian, MH. Ghahremani, M. Amini

Artificial cells, nanomedicine, and biotechnology, Year. 2016, Page:1-10,

90. . Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin

Authors: NSH. Motlagh, P. Parvin, F. Ghasemi, F. Atyabi

Biomedical Optics Express, Vol.7, No.6, Year. 2016, Page:2400-2406,

91. Carbon nanotube-anandamide complex exhibits sustained protective effects in an in vitro model of stroke

Authors: P. Hassanzadeh, E. Arbabi, F. Atyabi, R. Dinarvand

Physiology and Pharmacology, Vol.20, No.1, Year. 2016, Page:12-23,

92. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes

Authors: A. Razzazan, F. Atyabi, B. Kazemi, R. Dinarvand

Materials Science and Engineering: C, Year. 2016,

93. , A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells

Authors: Z. Hesari, M. Soleimani, F. Atyabi, M. Sharifdini, S. Nadri, M. Ebrahimi Warkiani, M. Zare, R. Dinarvand

Journal of Biomedical Materials Research Part A, Year. 2016,

94. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer

Authors: M. Azhdarzadeh, F. Atyabi, A. A. Saei, B. Shiri Varnamkhasti, Y. Omidi, M. Fateh, M. Ghavami, S. Shanehsazzadeh, R. Dinarvand

Colloids and Surfaces B: Biointerfaces, Year. 2016,

95. Enhanced cytotoxicity to cancer cells by co-delivery and controlled release of paclitaxel-loaded sirolimus conjugated albumin nanoparticles

Authors: H. Behrouz, M. Esfandyari-Manesh, M. K. Khoeeniha, M. Amini, B. Shiri Varnamkhasti, F. Atyabi, R. Dinarvand

Chemical Biology & Drug Design, Year. 2016,

96. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery; characterization and cellular cytotoxicity

Authors: M. Esfandyari-Manesh, B. Darvishi, F. Azizi Ishkuh, E. Shahmoradi, A. Mohammadi, M. Javanbakht, R. Dinarvand, F. Atyabi

Materials Science and Engineering: C, Year. 2016,

97. Self assembled Hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa

Authors: S.Y. Vafaei, M. Esmaeili, M. Amini, F. Atyabi, S.N. Ostad, R. Dinarvand

Carbohydrate Polymers, Year. 2016,

98. Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study

Authors: M. Kiani, F. Mirzazadeh, M. Dinarvand, M. Soleimani, R. Dinarvand, F. Atyabi,

Materials Science and Engineering: C, Year. 2016,

99. , Influence of PEG Molecular Weight on the Drug Release and In Vitro Cytotoxicity of Single-Walled Carbon Nanotubes-PEG-Gemcitabine Conjugates

Authors: A. Razzazan, F. Atyabi, B. Kazemi, R. Dinarvand,

Europe PMC plus, Year. 2016,

100. Carbon nanotubes prolong the regulatory action of nerve growth factor on the endocannabinoid signaling

Authors: P. Hassanzadeh , E. Arbabi, F. Rostami, F. Atyabi , R. Dinarvand

Physiol Pharmacol, Vol.19, Year. 2015, Page:167-176 ,

101. The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders

Authors: P. Hassanzadeh, E. Arbabi, F. Atyabi, R. Dinarvand

Psychopharmacology, Year. 2016,

102. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process

Authors: S. Mirsadeghi, S. Shanehsazzadeh, F. Atyabi, R. Dinarvand

Materials Science and Engineering C, Vol.59, Year. 2016, Page:390-397,

103. Biotin/Folate decorated human serum albumin‐nanoparticles of docetaxel: Comparison of chemically conjugated nanostructures and physically loaded nanoparticles for targeting of breast cancer

Authors: N. Nateghian, N. Goodarzi, M. Amini, F. Atyabi, M. R. Khorramizadeh, R. Dinarvand

Chemical biology & drug design, Vol.87, Year. 2016, Page:69-82,

104. Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles

Authors: F. Jadidi-Niaragh, F. Atyabi, A. Rastegari, E. Mollarazi, M. Kiani, A. Razavi, M. Yousefi, N. Kheshtchin, H. Hassannia, J. Hadjati, F. Shokri,

Tumor Biology, Year. 2016,

105. Chitosan polyplex nanoparticle vector for miR-145 expression inMCF-7: Optimization by design of experiment

Authors: F.S. Mirzazadeh Tekie, F. Atyabi, M. Soleimanic,E. Arefian, A. Atashi, M. Kiani, M.R. Khoshayand,M. Amini, R. Dinarvand

International Journal of Biological Macromolecules, No.81, Year. 2015, Page:828–837,

106. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles

Authors: B. S. Varnamkhasti, H. Hosseinzadeh, M. Azhdarzadeh, S. Y. Vafaei, M. Esfandyari-Manesh, Z. H. Mirzaie, M. Amini, S. N. Ostad, F. Atyabi, R. Dinarvand

International Journal of Pharmaceutics, Year. 2015,

107. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing

Authors: M. Hajimiri, S. Shahverdi, M. A. Esfandiari, B. Larijani, F. Atyabi, A. Rajabiani, A. R. Dehpour, M. Amini, R. Dinarvand

Drug development and industrial pharmacy, Year. 2015,

108. Cationic Albumin-Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration

Authors: G. Kamalinia, F. Khodagholi, F. Shaerzadeh, F. Tavssolian, F. Chaharband, F. Atyabi, M. Sharifzadeh, M. Amini, R. Dinarvand

Chemical Biology & Drug Design, Year. 2015,

109. 1. Preparation and Antibacterial Activity Evaluation of 18-β-glycyrrhetinic Acid Loaded PLGA Nanoparticles

Authors: Behrad Darvishi Saeed Manoochehri, Golnaz Kamalinia ,Nasrin Samadi, Mohsen Amini, Seyyed Hossein Mostafavi, Shahab Maghazei, Fatemeh Atyabi, and Rassoul Dinarvand

Iran J Pharm Res, Vol.14, No.2, Year. 2015, Page:373-383,

110. 1. Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles

Authors: Marzieh Kordezangeneh, Shiva Irani, Reza Mirfakhraie, Mehdi Esfandyari-Manesh, Fatemeh Atyabi, Rassoul Dinarvand

Medical Oncology,

111. 1. Development of 153Sm-folatepolyethyleneimine-conjugated chitosan nanoparticles for targeted therapy

Authors: Esmail Mollarazi, Amir R. Jalilian, Fariba Johari-daha, and Fatemeh Atyabi,

J. Label Compd. Radiopharm, Vol.58, Year. 2015, Page:327–335,

112. 2. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA 5 nanopolymersomes in mouse breast cancer model

Authors: Mona Alibolandi, Fatemeh Sadeghi, Khalil Abnous, Fatemeh Atyabi, Mohammad Ramezani, Farzin Hadizadeh

European Journal of Pharmaceutics and Biopharmaceutics, Year. 2015,

113. EGF-loaded Nanofibrous Scaffold for Skin Tissue Engineering Applications

Authors: Mohammad Norouzi, Iman Shabani1, Fatemeh Atyabi2, and Masoud Soleimani

Fibers and Polymers, Vol.16, No.4, Year. 2015, Page:782-787,

114. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles.

Authors: Darvishi B, Manoochehri S, Esfandyari-Manesh M, Samadi N, Amini M, Atyabi F, Dinarvand R.

Drug Res (Stuttg)., Year. 2015,

115. Synthesis, Characterization and Effect of the AntibacterialActivity of Chitosan Nanoparticles on Vancomycin-Resistant Enterococcus and Other Gram Negative or Gram Positive Bacteria

Authors: Neda Soleimani, Ashraf Mohabati Mobarez, Mahroo Seyed Jafari Olia and Fatemeh Atyabi,

Int. J. Pure Appl. Sci. Technol., Vol.26, No.1, Year. 2015, Page:14-23,

116. 4. Controlled release of rhEGF and rhbFGF from electrospun scaffolds for skin regeneration

Authors: Omolbanin Mirdailami, Masoud Soleimani, Rassoul Dinarvand, Mohammad Reza Khoshayand, Mohammad Norouzi, Athena Hajarizadeh, Masumeh Dodel and Fatemeh Atyabi.

J Biomed Mater Res A. , Year. 2015,

117. Determination of nanoparticles using UV-Vis spectra

Authors: Shahed Behzadi, Forough Ghasemi, Masoumeh Ghalkhani, Ali Akbar Ashkarran, Seyed Mostafa Akbari, Sepideh Pakpour, Mohammad Reza Hormozi-Nezhad, Zahra Jamshidi, Somayyeh Mirsadeghi, Rassoul Dinarvand, Fatemeh Atyabi and Morteza Mahmoudi

Nanoscale, Vol.7, No.12, Year. 2015, Page:5134-5139,

118. Albuminated PLGA nanoparticles containing bevacizumabintended for ocular neovascularization treatment

Authors: Reyhaneh Varshochian, Mohammad Riazi-Esfahani, Mahmood Jeddi-Tehrani, Ahmad-Reza Mahmoudi, Sara Aghazadeh, Mirgholamreza Mahbod, Morteza Movassat, Fatemeh Atyabi, Araz Sabzevari, Rassoul Dinarvand

J Biomed Mater Res A, Year. 2015,

119. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging

Authors: Shahriar Sharifi, Hajar Seyednejad, Sophie Laurent, Fatemeh Atyabi, Amir Ata Saei and Morteza Mahmoudi

Contrast media & molecular imaging , Year. 2015,

120. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.

Authors: …, M Amini, B Darvishi, SN Ostad, F Atyabi

Daru, Year. 2015,

121. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer

Authors: M. Alibolandi, M. Ramazanni, Kh. Abnous, F. Sadeghi, F. Atyabi, M. Asouri, A. A. Ahmadi, F. Haduzadeh

Journal of Controlled release, Year. 2015,

122. Functionalized nanoscale β-1,3-glucan to improve Her2 + breast cancer

Authors: Zahra Nasrollahi, Shahla Roudbar Mohammadi, Esmail Mollarazi, Mohammad

Journal of controlled released, Year. 2015,

123. Silk fibroin nanoparticle as a novel drug delivery system

Authors: Fatemeh Atyabi , Hossein Hosseinkhani , Fatemeh Mottaghitalab, Mehdi Farokhi , Mohammad Ali Shokrgozar ,

Journal of Controlled Release, No.206, Year. 2015, Page:161–176,

124. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process

Authors: Somayeh Mirsadeghi, Rassoul Dinarvand, Mohammad Hossein Ghahremani,Mohammad Reza Hormozi-Nezhad, Zohreh Mahmoudi,

Nanoscale, Year. 2015,

125. Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer

Authors: Dinarvand M, Kiani M, Mirzazadeh F, Esmaeili A, Mirzaie Z, Soleimani M, Dinarvand R, Atyabi F

Int J Biol Macromol, Vol.78, Year. 2015, Page:112-121,

126. The effect of fibronectin on structural and biological properties ofsingle walled carbon nanotube

Authors: Fatemeh Mottaghitalab, Mehdi Farokhi, Fatemeh Atyabi, Ramin Omidvar,Mohammad Ali Shokrgozar, Majid Sadeghizadeh,

Applied Surface Science, No.339, Year. 2015, Page:85–93,

127. Aptamer decorated hyaluronan/chitosan nanoparticles for targeteddelivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas

Authors: Zahra Ghasemia, Rassoul Dinarvandb, Fatemeh Mottaghitalabb,Mehdi

Carbohydrate Polymers, Vol.121, Year. 2015, Page: 190–198,

128. Piperazine and its carboxylic acid derivatives-functionalized mesoporous silica as nanocarriers for gemcitabine: Adsorption and release study

Authors: Z Bahrami, A Badiei, F Atyabi, HR Darabi…

Materials Science and Engineering: C, Vol.49, Year. 2015, Page:66–74,

129. Amniotic Membrane Extract Preparation: What is the

Authors: Mirgholamreza Mahbod; Saied Shahhoseini; Mehdi Khabazkhoob; Amir-Houshang Beheshtnejad; Haleh Bakhshandeh; Fatemeh Atyabi; Hassan Hashemi,

Journal of Ophthalmic and Vision Research, Vol.9, No.3, Year. 2014,

130. Piperazine and its carboxylic acid derivatives-functionalized mesoporous silica as nanocarriers for gemcitabine: Adsorption and release study

Authors: Zohreh Bahrami , Alireza Badiei ,Fatemeh Atyabi , Hossein Reza Darabi , Bita Mehravi

Materials Science and Engineering C, Year. 2014,

131. Healing Efficacy of an EGF Impregnated Triple Gel Based Wound Dressing: In Vitro and In Vivo Studies

Authors: Najmeh Khanbanha, Fatemeh Atyabi, Azade Taheri, Fatemeh Talaie,

BioMed Research International, Year. 2014,

132. Utilizing liposomes and lipid nanoparticles to overcome challenges in breast cancer treatment

Authors: Reyhaneh Varshochian, Hosniyeh Hosseinzadeh, Narges Gandomi​‌, Faranak Tavassolian, Fatemeh Atyabi​ & Rassoul Dinarvand​‌

Clinical Lipidology, Vol.9, Year. 2014, Page:571-585,

133. Preparation and antibacterial activity evaluation of 18-β-glycyrrhetinic acid loaded PLGA nanoparticles

Authors: Behrad Darvishi; Saeed Manoochehri; Golnaz Kamalinia; Seyyed Hossein Mostafavi; Shahab Maghazei; Nasrin Samadi; Mohsen Amini; Fatemeh Atyabi; Rassoul Dinarvand

Iranian Journal of Pharmaceutical Research, Year. 2014,

134. Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells

Authors: Tahamtan A1, Tabarraei A, Moradi A, Dinarvand M, Kelishadi M, Ghaemi A, Atyabi F.

Nanomedicine, and Biotechnology, Year. 2014,

135. Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems 

Authors: Tahamtan, A. , Ghaemi, A. , Gorji, A. , Kalhor, H.R. , Sajadian, A. , Tabarraei, A. , Moradi, A. , Atyabi, , Kelishadi, M.

Journal of Biomedical Science, Vol.21, No.1, Year. 2014,

136. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery 

Authors: Sayari, E., Dinarvand, M., Amini, M., Azhdarzadeh, M., Mollarazi, E., Ghasemi, Z., Atyabi, F.

International Journal of Pharmaceutics, Vol.473, No.1-2, Year. 2014, Page: 304-315,

137. Cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: Preparation, optimization and in vitro characterization 

Authors: Jafari Malek, S., Khoshchehreh, R., Goodarzi, N., Khoshayand, M.R., Amini, M., Atyabi, F., Esfandyari-manesh, M., Tehrani, S., Mohammad Jafari, R., Maghazei, M.S., Alvandifar, F., Ebrahimi, M. , Dinarvand, R.

Colloids and Surfaces B: Biointerfaces, Vol.122, Year. 2014, Page: 350-358,

138. Fabrication and structure analysis of poly(lactide-co-glycolic acid)/silk fibroin hybrid scaffold for wound dressing applications

Authors: Shahverdi, S., Hajimiri, M., Esfandiari, M.A., Larijani, B., Atyabi, F., Rajabiani, A., Dehpour, A.R., Gharehaghaji, A.A., Dinarvand, R.

International Journal of Pharmaceutics, Vol.473, No.1-2, Year. 2014, Page: 345-355,

139. SN38 polymeric nanoparticles: In vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan

Authors: Sepehri, N., Rouhani, H., Tavassolian, F., Montazeri, H., Khoshayand, M.R., Ghahremani, M.H., Ostad, S.N., Atyabi, F., Dinarvand, R.

International Journal of Pharmaceutics, Vol.471, No.1-2, Year. 2014, Page: 485-497,

140. Targeted poly (l-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells 

Authors: Tavassolian, F., Kamalinia, G., Rouhani, H., Amini, M., Ostad, S.N.e, Khoshayand, M.R.f, Atyabi, F.ab, Tehrani, M.R.a, Dinarvand, R.

International Journal of Pharmaceutics, Vol.467, No.1-2, Year. 2014, Page:123-138,

141. Doxorubicin loaded folate-targeted carbon nanotubes: Preparation, cellular internalization, in vitro cytotoxicity and disposition kinetic study in the isolated perfused rat liver 

Authors: Dinan, N.M., Atyabi, F. , Rouini, M.-R., Amini, M., Golabchifar, A.-A.a, Dinarvand, R.

Materials Science and Engineering C, Vol.39, No.1, Year. 2014, Page:47-55,

142. Zinc Protoporphyrin Polymeric Nanoparticles: Potent Heme Oxygenase Inhibitor for Cancer Therapy 

Authors: Rouhani, H., Sepehri, N., Montazeri, H., Khoshayand, M.R., Ghahremani, M.H., Ostad, S.N., Atyabi, F.ab, Dinarvand, R.

Pharmaceutical Research, Year. 2014,

143. Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: Optimization and in vivo evaluation

Authors: Aboutaleb, E., Atyabi, F., Khoshayand, M.R., Vatanara, A.R., Ostad, S.N., Kobarfard, F., Dinarvand, R.

Journal of Biomedical Materials Research - Part A, Vol.102, No.7, Year. 2014, Page:2125-2136,

144. CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: A novel hyaluronic acid-based drug delivery system 

Authors: Goodarzi, N., Ghahremani, M.H., Amini, M., Atyabi, F., Ostad, S.N., Shabani Ravari, N., Nateghian, N., Dinarvand, R.

Chemical Biology and Drug Design, Vol.83, No.6, Year. 2014, Page: 741-752,

145. Healing efficacy of an EGF impregnated triple gel based wound dressing: In vitro and in vivo studies 

Authors: Khanbanha, N. , Atyabi, F. , Taheri, A. , Talaie, F. , Mahbod, M.c , Dinarvand, R.

BioMed Research International, Year. 2014,

146. Release optimization of epidermal growth factor from PLGA microparticles

Authors: Mirdailami, O., Khoshayand, M.R., Soleimani, M., Dinarvand, R., Atyabi, F.

Pharmaceutical Development and Technology, Vol.19, No.5, Year. 2014, Page:539-547,

147. Docetaxel loaded PEG-PLGA nanoparticles: Optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect 

Authors: Koopaei, M.N., Khoshayand, M.R., Mostafavi, S.H.b, Amini, M., Khorramizadeh, M.R., Tehrani, M.J., Atyabi, F., Dinarvand, R.

Iranian Journal of Pharmaceutical Research, Vol.13, No.3, Year. 2014, Page:819-834,

148. Synthesis and characterization of paclitaxel-imprinted nanoparticles for recognition and controlled release of an anticancer drug

Authors: Ishkuh, F.A.a, Javanbakht, M. , Esfandyari-Manesh, M., Dinarvand, R, Atyabi, F

Journal of Materials Science, Vol.49, No.18, Year. 2014, Page:6343-6352,

149. Chitosan–pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells

Authors: Malakooty Poor E1, Baghaban Eslaminejad M, Gheibi N, Bagheri F, Atyabi F.

Artificial Cells, Nanomedicine, and Biotechnology, Vol.42, Year. 2014, Page: 376-384,

150. Surface functionalization of SBA-15 nanorods for anticancer drug delivery 

Authors: Bahrami, Z., Badiei, A. , Atyabi, F.

Chemical Engineering Research and Design, Vol.92, No.7, Year. 2014, Page: 1296-1303,

151. Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: Optimization and in vivo evaluation

Authors: Aboutaleb E, Atyabi F, Khoshayand MR, Vatanara AR, Ostad SN, Kobarfard F, Dinarvand R.

J Biomed Mater Res A, Year. 2013,

152. Recent approaches to overcoming multiple drug resistance in breast cancer using modified liposomes

Authors: Rassoul Dinarvand, Reyhaneh Varshochian, Golnaz Kamalinia, Navid Goodarzi & Fatemeh Atyabi

Clin. Lipidol, Vol.8, No.4, Year. 2013, Page:391–394,

153. Study of antimicrobial activity of anethole and carvoneloaded PLGA nanoparticles

Authors: Mehdi Esfandyari-Manesh, Zahra Ghaedi, Mahboobeh Asemi , Mahnaz Khanavi,Azadeh Manayi, Hossein Jamalifar d, Fatemeh Atyabi, Rassoul Dinarvand

j o u rnal of pharmacy r e s e a r c h , Year. 2013,

154. Release optimization of epidermal growth factor fromPLGA microparticles

Authors: Omolbanin Mirdailami, Mohammad Reza Khoshayand, Masoud Soleimani, Rassoul Dinarvand, and Fatemeh Atyabi

Pharm Dev Technol, Year. 2013,

155. Surface modification of PLGA nanoparticles via vhuman serum albumin conjugation for controlled

Authors: Saeed Manoochehri, Behrad Darvishi, Golnaz Kamalinia, Mohsen Amini, Mahdieh Fallah, Seyed Naser Ostad,Fatemeh Atyabi and Rassoul Dinarvand

DARU Journal of Pharmaceutical Sciences , Vol.21, No.58, Year. 2013,

156. Chitosan–pDNA nanoparticle characteristics determine the transfectioneffi cacy of gene delivery to human mesenchymal stem cells

Authors: Elham Malakooty Poor, Mohamadreza Baghaban Eslaminejad , Nematollah Gheibi , Fatemeh Bagheri & Fatemeh Atyabi

Artifi cial Cells, Nanomedicine, and Biotechnology, Year. 2013,

157. Modified Gadonanotubes as a promising novelMRI contrasting agent

Authors: Rouzbeh Jahanbakhsh, Fatemeh Atyabi , Saeed Shanehsazzadeh, Zahra Sobhani, Mohsen Adeli and Rassoul Dinarvand

Jahanbakhsh et al. DARU Journal of Pharmaceutical Sciences , Vol.21, No.53, Year. 2013,

158. Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery.

Authors: J Varshosaz, S Ghaffari, S F Mirshojaei, A Jafarian, F Atyabi, F Kobarfard, S Azarmi

BioMed research international , Vol.2013, Year. 2013,

159. Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies

Authors: Golnaz Kamalinia, Fariba Khodagholi, Fatemeh Atyabi, Mohsen Amini, Fatemeh Shaerzadeh, Mohammad Sharifzadeh, and Rassoul Dinarvand

Mol. Pharmaceutics, Year. 2013,

160. Overcoming therapeutic obstacles in inflammatory bowel diseases: A4 comprehensive review on novel drug delivery strategies

Authors: Talaie ,F., F. Atyabi, , M. Azjdarzadeh, R. Dinarvand , A. Saadatzadeh

European Journal of Pharmaceutical Sciences,

161. Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies

Authors: Talaei, F., Atyabi, F. , Azjdarzadeh, M., Dinarvand, R., Saadatzadeh, A.

European Journal of Pharmaceutical Sciences, Vol.49, No.4, Year. 2013, Page:712-722,

162. Protein encapsulated in electrospun nanofibrous scaffolds for tissue engineering applications

Authors: Norouzi, M., Soleimani, M., Shabani, I., Atyabi, F., Ahvaz, H.H., Rashidi, A.

Polymer International, Year. 2013,

163. Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles

Authors: Koopaei, Mona Noori; Maghazei, Mohamad Shahab; Mostafavi, Seyed Hossein; et al.

Daru-Journal Of Pharmaceutical Sciences , Vol.20,

164. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: In vitro and in vivo studies

Authors: Sabzevari, A., Adibkia, K., Hashemi, H., Hedayatfar, A., Mohsenzadeh, N., Atyabi, F., Ghahremani, M.H., Dinarvand, R.

European Journal of Pharmaceutics and Biopharmaceutics, Vol.84, No.1, Year. 2013, Page:63-71,

165. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide

Authors: Erfani Jabarian, L., Rouini, M.R., Atyabi, F., Foroumadi, A., Nassiri, S.M., Dinarvand, R.

European Journal of Pharmaceutical Sciences, Vol.48, No.1, Year. 2013, Page:87-96,

166. A review of polysaccharide cytotoxic drug conjugates for cancer therapy

Authors: Goodarzi, N., Varshochian, R., Kamalinia, G. Atyabi, F., Dinarvand, R.

Carbohydrate Polymers , Vol.92, No.2, Year. 2013, Page:1280-1293,

167. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design

Authors: Varshosaz, Jaleh; Ghaffari, Solmaz; Khoshayand, Mohammad Reza; et al.

Pharmaceutical Development And Technology , Vol.17, No.2, Year. 2012, Page:187-194 ,

168. Molecularly imprinted nanoparticles prepared by miniemulsion polymerization as selective receptors and new carriers for the sustained release of carbamazepine

Authors: Esfandyari-Manesh, Mehdi; Javanbakht, Mehran; Dinarvand, Rassoul; et al.

Journal of materials science-materials in medicine , Vol.23, No.4, Year. 2012, Page:963-972 ,

169. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge

Authors: Kheiri, M.T., Jamali, A., Shenagari, M., Hashemi, H., Sabahi, F., Atyabi, F., Saghiri, R.

Antiviral Research, Vol.95, No.3, Year. 2012, Page:229-236,

170. PEGylation of octreotide using an α,β-unsaturated-β′-mono-sulfone functionalized PEG reagent

Authors: Erfani-Jabarian, L., Dinarvand, R., Rouini, M.R., Atyabi, F., Amini, M., Mohammadhosseini, N., Shafiee, A., Foroumadi, A.

Iranian Journal of Pharmaceutical Research, Vol.11, No.3, Year. 2012, Page:747-753,

171. Targeted Delivery of Methotrexate to Tumor Cells Using Biotin Functionalized Methotrexate-Human Serum Albumin Conjugated Nanoparticles

Authors: Taheri, Azade; Dinarvand, Rassoul; Atyabi, Fatemeh; et al.

Journal of biomedical nanotechnology , Vol.7, No.6, Year. 2011, Page:743-753 ,

172. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells

Authors: Taheri, A., Dinarvand, R., Atyabi, F., Ghahremani, M.H., Ostad, S.N.

European Journal of Pharmaceutical Sciences, Vol.47, No.2, Year. 2012, Page:331-340 ,

173. Solid lipid nanoparticles of ciprofloxacin hydrochloride with enhanced antibacterial activity

Authors: N. Gandomi, E. Aboutaleb, M. Noori, F. Atyabi, M.R. Fazeli, E. Farbod,H. Jamalifar, R. Dinarvand

Journal Of Nanoscience Letters, Year. 2012,

174. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice

Authors: Taheri, A., Dinarvand, R., Ahadi, F., Khorramizadeh, M.R., Atyabi, F.

International Journal of Pharmaceutics, Vol.431, No.1-2, Year. 2012, Page:183-189,

175. Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study

Authors: Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN

International Journal of Nanomedicine , Vol.2012, No.7, Year. 2012, Page:1851 - 1863,

176. Improved antimycobacterial activity of rifampinusing solid lipid nanoparticles

Authors: Ehsan Aboutaleb, Massoumeh Noori, Narges Gandomi, Fatemeh Atyabi, Mohammad Reza Fazeli, Hossein Jamalifar and Rassoul Dinarvand.

International Nano Letters , Vol.2, No.3, Year. 2012,

177. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method

Authors: Jafarzadeh Kashi TS, Eskandarion S, Esfandyari-Manesh M, Amin Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R.

International Journal of Nanomedicine, Vol.2012, No.7, Year. 2012, Page:221 - 234,

178. Experimental study and modeling of tissue plasminogen activators releaseencapsulated by chitosan coated poly(lactide-co-glycolide acid) nanoparticles

Authors: Mahboobeh Mahmoodia, Mohammad E. Khosroshahia, Fatemeh Atyabi, Afrooz Saadat zadeh

Phys. Express , Vol.2, No.6, Year. 2012,

179. Synthesis and evaluation of uniformly sized carbamazepine imprinted microspheres and nanospheres prepared with different mole ratios of methacrylic acid-to-methyl methacrylate for analytical and biomedical applications

Authors: Mehdi Esfandyari-Manesh , Mehran Javanbakht , Fatemeh Atyabi , Rassoul Dinarvand

Journal of Applied Polymer Science, Vol.125, No.3, Year. 2012, Page:1804-1813,

180. Dipyridamole recognition and controlled release by uniformly sized molecularly imprinted nanospheres

Authors: Mehdi Esfandyari-Manesh , Mehran Javanbakht , Fatemeh Atyabi , Ali Mohammadi Somayeh Mohammadi , Behrouz Akbari-Adergani , Rassoul Dinarvand

Materials Science and Engineering , Vol.31, No.8, Year. 2012, Page:1692-1699 ,

181. Physico-chemical properties investigation of cisplatin loaded poly butyladipate (PBA) nanoparticles prepared by w/o/w

Authors: Sepideh Khoee, Ahmad Sattari, Fatemeh Atyabi

Materials Science and Engineering: C, Vol.32, No.5, Year. 2012, Page:1078-1086 ,

182. Targeted drug delivery to cancer stem cells by hyaluronic acid-based drug onjugates: Synthesis and characterization

Authors: N. Goodarzi, M. Amini, F. Atyabi, R. Dinarvand

Research in Pharmaceutical Sciences, Vol.7, No.5, Year. 2012,

183. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.

Authors: Araz Sabzevari, Khosro Adibkia, Hassan Hashemi, Bruno G De Geest, Navid Mohsenzadeh, Fatemeh Atyabi, Mohammad Hossein Ghahremani, Mohammad Reza Khoshayand, Rassoul Dinarvand

Invest Ophthalmol Vis Sci., Vol.54, No.8,

184. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38

Authors: Ebrahimnejad, P., Dinarvand, R., Jafari, M.R., Tabasi, S.A.S., Atyabi, F

International Journal of Pharmaceutics, Vol.406, No.1-2, Year. 2011, Page:122-127,

185. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube

Authors: Z. Sobhani, R. Dinarvand , F Atyabi ,M ghahremani ,M Adeli

International Journal of Nanomedicine, Vol.6, Year. 2011, Page:705–719,

186. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

[link]

Authors: R Dinarvand, N Sepehri, S Manoochehri, H Rouhani, F Atyabi

International Journal of Nanomedicine , Vol.6, Year. 2011, Page:877 - 895 ,

187. Effect of Porogenic Solvent on the Morphology, Recognition and Release Properties of Carbamazepine-Molecularly Imprinted Polymer Nanospheres

Authors: Esfandyari-Manesh M Javanbakht M, Atyabi F, Badiei A, Dinarvand R

Journal of applied polymer science , Vol.121, No.2, Year. 2011, Page:1118-1126 ,

188. Quantum Dot-Pseudopolyrotaxane Supramolecules as Anticancer Drug Delivery Systems

Authors: F. Hakimpoor, M. Parsamanesh, M. Kalantari, Z. Sobhani, F. Attyabi, Mohsen Adeli

polymer, Vol.52, No.11, Year. 2011, Page:2401-2413 ,

189. Temperature-responsive and biodegradable PVA:PVP k30:poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH)

Authors: Azade Taheri1, Fatemeh Atyabi and Rassoul Dinarvnd

J Pediatr Endocr Met, Vol.24, No.3-4, Year. 2011, Page:175–179 ,

190. Poly (ε-caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two-part artificial cornea

Authors: Haleh Bakhshandeh, Masoud Soleimani, Saied Shah Hosseini, Hassan Hashemi, Iman Shabani, Abbas Shafiee, Amir Houshang Behesht Nejad, Mohammad Erfan, Rassoul Dinarvand, Fatemeh Atyabi

International journal of Nanomedicin, Vol.6, Year. 2011, Page:1509 – 1515 ,

191. Early experimental results of thrombolysis using controlled release of tissue plasminogen activator encapsulated by plga/cs nanoparticles delivered by pulse 532 nm laser

[link]

Authors: M. Mahmoodi, M. E. Khosroshahi ,F. Atyabi

Digest Journal Of Nanomaterials And Biostructures , Vol.6, No.3, Year. 2011,

192. Dynamic study of PLGA/CS nanoparticles delivery containing drug model into phantom tissue using CO(2) laser for clinical applications

Authors: Mahboobeh Mahmoodi, Mohammad E Khosroshahi and Fatemeh Atyabi

J. Biophotonics, Vol.4, No.6, Year. 2011, Page:403–414 ,

193. Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide

Authors: Azade Taheri, Rassoul Dinarvand , Fatemeh Atyabi, Fatemeh Ahadi, Farank Salman Nouri, Mohammad Hossein Ghahremani, Seyed Nasser Ostad, Atefeh Taheri Borougeni and Pooria Mansoori

Int. J. Mol. Sci, Vol.12, No.7, Year. 2011, Page:4591-4608 ,

194. Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticaner drugs: in vitroanalysis and evaluations

Authors: ParisaYousefpour, FatemehAtyabi, EbrahimVasheghani-Farahani, Ramin Sakhtianchi, RassoulDinarvand

International Journal of Nanomedicin, Vol.6, Year. 2011, Page:1487 – 1496 ,

195. Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles

[link]

Authors: Solmaz Ghaffari, Jaleh Varshosaz, Afrooz Saadat, Fatemeh Atyabi .

International Journal of Nanomedicine., Vol.6, Year. 2011, Page: 35 – 43 ,

196. Nanoparticles of ConjugatedMethotrexate-Human Serum Albumin: Preparation and Cytotoxicity Evaluations

Authors: Azade Taheri, Fatemeh Atyabi, Faranak Salman Nouri, Fatemeh Ahadi, Mohammad Ali Derakhshan, Mohsen Amini, Mohammad Hossein Ghahremani, Seyed Nasser Ostad, PooriaMansoori, and Rassoul Dinarvand

Journal of Nanomaterials, Year. 2011,

197. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation

Authors: Shahrooz Saremi, Fatemeh Atyabi, Seyedeh Parinaz Akhlaghi, Seyed Nasser Ostad, Rassoul Dinarvand

International Journal of Nanomedicine, Vol.6, Year. 2011, Page:119,

198. Preparation and Invitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline

Authors: Mahboubian A., Hashemin SK., Atyabi F. And Dinarvand R

Iranian Journal of Pharmaceutical Resea